Back to IGF-1 LR3
IGF-1 LR3 Dosage Guide
Complete dosing protocol, reconstitution steps, and interactive calculator for IGF-1 LR3.
Dosing & Reconstitution Guide
In preclinical studies, IGF-1 LR3 is used at 20–100 μg/kg depending on species and study design. These values do not translate to safe or approved human dosing.
Standard / Gradual Approach
1mg VialstandardPhaseDoseVolume
Week 1-220 mcg daily6 units
Week 3-440 mcg daily12 units
Week 5+60-80 mcg daily, cycle 4 weeks on / 4 weeks off18 units
Protocol Summary
Subcutaneous (SQ): Daily · Dose range 30–100 mcg with gradual titration
Cycle Length: 4–8 weeks typical; reassess before extending
Frequency & Cycling
SubQ Injection
Administer daily at 40–100 mcg post-exercise or in the morning. Suggested cycle: 4–6 weeks on, 4 weeks off to avoid receptor desensitization.
🧪 Quick Start
Vial Size
1 mg
BAC Water
3 mL
Concentration
300 mcg/unit
Starting Dose
20 mcg daily
Maintenance Dose
40-80 mcg daily
🧮 Dose Calculator
Concentration
3.3
mcg/unit
Draw Volume
150
units (1.500 mL)
For a 500 mcg dose, draw 150 units on a U-100 insulin syringe